Chirality-Promoted Chemical Ligation and Reverse Transcription of Acyclic Threoninol Nucleic Acid
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c03128 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Hikari Okita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Engineering, Nagoya University, Nagoya 464-8603, Japan. Hauptthemen laut MEDLINE: Reverse Transcription, Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, ACT-X, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate School of Engineering, Nagoya University, Nagoya 464-8603, Japan.
ORCID-Profile: Hikari Okita, Keiji Murayama, Hiroyuki Asanuma
Förderung
- Japan Agency for Medical Research and Development
- ACT-X
- Japan Society for the Promotion of Science
- Fusion Oriented REsearch for disruptive Science and Technology
Zitieren
APA
Okita, H., Murayama, K., & Asanuma, H. (2025). Chirality-Promoted Chemical Ligation and Reverse Transcription of Acyclic Threoninol Nucleic Acid. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c03128
Vancouver
Okita H, Murayama K, Asanuma H. Chirality-Promoted Chemical Ligation and Reverse Transcription of Acyclic Threoninol Nucleic Acid. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c03128
BibTeX
@article{Okita2025,
author = {Okita, Hikari and Murayama, Keiji and Asanuma, Hiroyuki},
title = {Chirality-Promoted Chemical Ligation and Reverse Transcription of Acyclic Threoninol Nucleic Acid},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c03128}
}
EUVIMED